Search

everythinglearnresearchcommunity

for

Search:↓

Betulinic acid can help treat hepatitis C by stopping virus replication.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Modulating the BTNL2 pathway can prevent hair loss in mice.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Calancardin B may help reduce inflammation in immune cells.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

The new drug delivery system effectively targets lung cancer cells.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

PBMCsec can help reduce and improve thick skin scars.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Zinc can reverse hair loss caused by the anthrax vaccine.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Combining stem cells and targeted treatments can improve muscle and skin healing after cleft repair.

The treatment was effective for lupus nephritis with manageable side effects.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

A 2-year-old boy with a rare type of lupus causing hair loss improved with oral steroids.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Donors on most medications can donate certain blood products without waiting, except for specific drugs that need a waiting period.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Bismuth subgallate and borneol together improve skin wound healing better than when used separately or compared to other treatments.